DUALITY ADVISERS, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$425,890
-81.2%
5,415
-87.3%
0.05%
-80.4%
Q4 2021$2,261,000
-42.2%
42,637
-27.3%
0.24%
-29.4%
Q2 2021$3,910,000
+21.9%
58,671
+103.1%
0.35%
+24.8%
Q1 2021$3,208,000
-21.9%
28,894
-19.2%
0.28%
+13.5%
Q4 2019$4,107,00035,7450.24%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders